Company Overview and News

 
3 Blue-Chip Trades That You Win No Matter What

1h investorplace
Options are mistakenly considered exotic securities by the average investor. Like all investments, they can be very risky, but if used properly, they can provide a steady and reliable additional source of income.
Upvote Downvote

 
Nike's vice president of Express Lane Footwear leaves company (April 18)

5h channelnewsasia
Nike Inc's vice president of footwear, Greg Thompson, has left the company, a company spokesman said on Wednesday, the latest in a string of executive departures at the sportswear maker.
Upvote Downvote

 
Fourth executive out at Nike as VP of footwear leaves-Portland Business Journal - MarketWatch

10h marketwatch
A fourth executive has left Nike Inc. NKE, -1.94% the Portland Business Journal reported on Thursday, as the company continues with a culture change aimed at creating a more diverse leadership. Greg Thompson, the company's vice president of footwear, left the company Thursday after decades at Nike, the paper reported. On Wednesday, The Wall Street Journal said that Vikrant Singh, a senior brand director for the basketball brand in North America, and Daniel Tawiah, vice president of global brand digital-marketing innovation, were being forced to leave the company.
Upvote Downvote

 
Nike's vice president of footwear quits - Channel NewsAsia

18h channelnewsasia
Nike Inc's vice president of footwear, Greg Thompson, has left the company, a company spokesman said on Wednesday, the latest in a string of executive departures at the sportswear maker.
Upvote Downvote

 
Nike's vice president of footwear quits

19h reuters
(Reuters) - Nike Inc’s (NKE.N) vice president of footwear, Greg Thompson, has left the company, a company spokesman said on Wednesday, the latest in a string of executive departures at the sportswear maker.
Upvote Downvote

 
FANG Is Leading The Charge - Cramer's Mad Money (4/17/18)

2018-04-18 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, April 17.
Upvote Downvote

 
PRESS DIGEST- Wall Street Journal - April 18

2018-04-18 reuters
April 18 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
More Senior Executives Exit Nike - WSJ

2018-04-18 wsj
Three additional Nike Inc. executives have left the company, including the head of diversity and a senior manager in the basketball business, according to people familiar with the matter.
Upvote Downvote

2
Why eBay Inc Stock Could Keep Falling Even Lower

2018-04-17 investorplace
Digital retail marketplace eBay Inc (NASDAQ:EBAY) started 2018 off on the right foot. Thanks mostly to better-than-expected fourth-quarter numbers, eBay stock roared more than 20% higher in the first month of 2018 to all time highs of nearly $47.
Upvote Downvote

 
Confusing Sports with Sportswear Keeps Hurting Under Armour Inc Stock

2018-04-17 investorplace
Under Armour Inc. (NYSE:UAA) is up for the year and has some backing on Wall Street, but Under Armour stock is not all the way back by any means.
Upvote Downvote

 
BRIEF-Nike Inc's VP Of Diversity And Inclusion Antoine Andrews Has Left Company- Spokeswoman

2018-04-16 reuters
* NIKE INC’S VP OF DIVERSITY AND INCLUSION ANTOINE ANDREWS HAS LEFT COMPANY- SPOKESWOMAN Further company coverage:
Upvote Downvote

 
Victory Formation Long/Short Portfolio Update - Buy Gold, Oil And Disney

2018-04-16 seekingalpha
Gold, oil and commodity related assets in March-April are driving gains on the long side of the ledger.
Upvote Downvote

 
Nike’s Head of Diversity Leaves During Review of Corporate Culture - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
The Digital Economy, The Tech Titans And Why They Matter For All Investors

2018-04-16 seekingalpha
Scale is less of a competitive advantage than it used to be; smaller firms are now better placed to breach the economic moats of the dominant players in their industry.
Upvote Downvote

 
Intel Reclaims Spot as Top-Performing Dow Stock in 2018

2018-04-14 247wallst
Intel Corp. (NASDAQ: INTC) stock rode a wave of investor keenness for technology shares last week, posting a weekly share price gain of 6.3% to return to its ranking as the top-performing Dow Jones industrial average stock of the year to date. The chipmaker’s shares are up 12.4% so far in 2018.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 654106103